Fortitude Family Office’s STAAR Surgical STAA Stock Holding History

Fortitude Family Office’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-155	Closed	-$2.6K	–	2133
2025 Q2	$2.6K	Buy	+155	New	+$2.73K	﹤0.01%	1063

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Fortitude Family Office's STAA Position: Q3 2025 in Review

Fortitude Family Office sold out of STAAR Surgical (STAA) in Q3 2025, closing a stake of 155 shares — an estimated $2.6K sold.

Fortitude Family Office first reported a position in STAA in Q2 2025 and held it in 1 quarter. The position peaked at $2.6K in Q2 2025. 196 funds tracked by Wall St. Rank hold STAA as of Q3 2025.

Fortitude Family Office reported no remaining STAAR Surgical position as of Q3 2025 after selling out during the quarter.
Fortitude Family Office sold 155 STAAR Surgical shares in Q3 2025, an estimated $2.6K.
Fortitude Family Office first reported a position in STAAR Surgical in Q2 2025 and held it in 1 quarter.
Fortitude Family Office's STAAR Surgical position peaked at $2.6K in Q2 2025.
196 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2025.

Based on Fortitude Family Office's 13F filing for Q3 2025, filed 17 Oct 2025.